Yüklüyor......
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment
The opioid crisis is a significant public health issue with more than 115 people dying from opioid overdose per day in the United States. The aim of the present study was to characterize the in vitro and in vivo pharmacological effects of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-...
Kaydedildi:
| Yayımlandı: | ACS Chem Neurosci |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6520168/ https://ncbi.nlm.nih.gov/pubmed/30758946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.9b00038 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|